Total Valuation
Shandong Weigao Group Medical Polymer Co has a market cap or net worth of €1.68B. The enterprise value is €20.29K.
Market Cap€1.68B
Enterprise Value€20.29K
Share Statistics
Shandong Weigao Group Medical Polymer Co has 4,522,332,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,522,332,500
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Shandong Weigao Group Medical Polymer Co’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 4.60%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.60%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee1.01M
Profits Per Employee152.66K
Employee Count13,307
Asset Turnover0.37
Inventory Turnover2.81
Valuation Ratios
The current PE Ratio of Shandong Weigao Group Medical Polymer Co is 8.3. Shandong Weigao Group Medical Polymer Co’s PEG ratio is -0.54.
PE Ratio8.3
PS Ratio1.55
PB Ratio0.86
Price to Fair Value0.86
Price to FCF12.09
Price to Operating Cash Flow5.25
PEG Ratio-0.54
Income Statement
In the last 12 months, Shandong Weigao Group Medical Polymer Co had revenue of 13.39B and earned 1.61B in profits. Earnings per share was 0.35.
Revenue13.39B
Gross Profit6.33B
Operating Income1.70B
Pretax Income2.03B
Net Income1.61B
EBITDA2.75B
Earnings Per Share (EPS)0.35
Cash Flow
In the last 12 months, operating cash flow was 2.61B and capital expenditures -1.73B, giving a free cash flow of 881.57M billion.
Operating Cash Flow2.61B
Free Cash Flow881.57M
Free Cash Flow per Share0.19
Dividends & Yields
Shandong Weigao Group Medical Polymer Co pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.18
52-Week Price Change-50.07%
50-Day Moving Average0.36
200-Day Moving Average0.47
Relative Strength Index (RSI)56.76
Average Volume (3m)277.00
Important Dates
Shandong Weigao Group Medical Polymer Co upcoming earnings date is Aug 25, 2026, TBA (Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateAug 25, 2026
Ex-Dividend Date―
Financial Position
Shandong Weigao Group Medical Polymer Co as a current ratio of 3.78, with Debt / Equity ratio of 24.83%
Current Ratio3.78
Quick Ratio3.32
Debt to Market Cap0.23
Net Debt to EBITDA-1.09
Interest Coverage Ratio6.82
Taxes
In the past 12 months, Shandong Weigao Group Medical Polymer Co has paid 320.79M in taxes.
Income Tax320.79M
Effective Tax Rate0.16
Enterprise Valuation
Shandong Weigao Group Medical Polymer Co EV to EBITDA ratio is 6.46, with an EV/FCF ratio of 10.34.
EV to Sales1.33
EV to EBITDA6.46
EV to Free Cash Flow10.34
EV to Operating Cash Flow6.97
Balance Sheet
Shandong Weigao Group Medical Polymer Co has €9.87B in cash and marketable securities with €5.99B in debt, giving a net cash position of €3.88B billion.
Cash & Marketable Securities€9.87B
Total Debt€5.99B
Net Cash€3.88B
Net Cash Per Share€0.86
Tangible Book Value Per Share€4.58
Margins
Gross margin is 47.26%, with operating margin of 12.69%, and net profit margin of 12.04%.
Gross Margin47.26%
Operating Margin12.69%
Pretax Margin15.17%
Net Profit Margin12.04%
EBITDA Margin20.56%
EBIT Margin13.79%
Analyst Forecast
The average price target for Shandong Weigao Group Medical Polymer Co is €0.72, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€0.72
Price Target Upside110.91% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-1.83%
EPS Growth Forecast-24.79%